Yuping Mei

1.9k total citations
18 papers, 1.2k citations indexed

About

Yuping Mei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuping Mei has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yuping Mei's work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Yuping Mei is often cited by papers focused on MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Yuping Mei collaborates with scholars based in United States, China and Hong Kong. Yuping Mei's co-authors include Feng Jiang, Jun Shen, Maria Guarnera, Lei Yu, Jipei Liao, David Clark, Mao Li, Zhenqiu Liu, Yun Su and Ting Li and has published in prestigious journals such as Nature Communications, PLoS ONE and Analytical Chemistry.

In The Last Decade

Yuping Mei

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuping Mei United States	9	904	730	246	144	116	18	1.2k
Suye Zhong China	5	871 1.0×	519 0.7×	96 0.4×	74 0.5×	18 0.2×	7	1.0k
Yunfei Wen United States	12	389 0.4×	169 0.2×	121 0.5×	65 0.5×	35 0.3×	23	675
Abel Bermudez United States	11	612 0.7×	171 0.2×	105 0.4×	73 0.5×	43 0.4×	32	797
Mingxu Song China	14	569 0.6×	513 0.7×	98 0.4×	65 0.5×	10 0.1×	24	795
Humberto J. Ferreira Spain	14	742 0.8×	255 0.3×	105 0.4×	58 0.4×	120 1.0×	15	924
Aashish Soni Germany	14	835 0.9×	245 0.3×	393 1.6×	171 1.2×	96 0.8×	29	1.0k
Andreas Kakarougkas United Kingdom	9	986 1.1×	202 0.3×	366 1.5×	117 0.8×	51 0.4×	12	1.1k
Chen Sun China	16	582 0.6×	282 0.4×	114 0.5×	629 4.4×	14 0.1×	34	1.1k
Michael P. Plebanek United States	16	650 0.7×	343 0.5×	345 1.4×	88 0.6×	12 0.1×	24	1.1k
Vanessa Bonazzi Australia	14	575 0.6×	293 0.4×	223 0.9×	84 0.6×	9 0.1×	27	784

Countries citing papers authored by Yuping Mei

Since Specialization

Citations

This map shows the geographic impact of Yuping Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuping Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuping Mei more than expected).

Fields of papers citing papers by Yuping Mei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuping Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuping Mei. The network helps show where Yuping Mei may publish in the future.

Co-authorship network of co-authors of Yuping Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Yuping Mei. A scholar is included among the top collaborators of Yuping Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuping Mei. Yuping Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rodgers, Kristen, James R. Eshleman, Peng Huang, et al.. (2025). PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapy. Non-coding RNA Research. 12. 34–41.

Mei, Yuping, et al.. (2023). pfeRNAs—A Novel Class of Small Non-coding RNAs With Real Translational Potential. Journal of Surgical Research. 284. 237–244. 2 indexed citations

Rodgers, Kristen, Christine Kim, Jinny S. Ha, et al.. (2023). Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine. Clinical Autonomic Research. 34(1). 191–201. 2 indexed citations

Rodgers, Kristen, Alicia Hulbert, Hamza Khan, et al.. (2022). A TRIzol-based method for high recovery of plasma sncRNAs approximately 30 to 60 nucleotides. Scientific Reports. 12(1). 6778–6778. 3 indexed citations

Mei, Yuping, et al.. (2019). Abstract 1822: A mitochondrial pfeRNA associates with Far Upstream Element Binding Protein 1 (FUBP1) to promote lung adenocarcinoma tumorigenesis. Cancer Research. 79(13_Supplement). 1822–1822. 1 indexed citations

Wang, Yuyan, Z. Mark, David Clark, et al.. (2017). A piRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma. Molecular Therapy — Nucleic Acids. 6. 269–278. 43 indexed citations

Wang, Yuyan, David Clark, Priti Kumari, et al.. (2017). A phosphorylation-wide sncRNA screen reveals Protein Functional Effector sncRNAs (pfeRNAs) in human lung somatic cells. Cancer Letters. 396. 85–93. 5 indexed citations

Brock, Malcolm V. & Yuping Mei. (2017). Protein functional effector sncRNAs (pfeRNAs) in lung cancer. Cancer Letters. 403. 138–143. 10 indexed citations

Mei, Yuping, Yuyan Wang, Priti Kumari, et al.. (2015). A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells. Nature Communications. 6(1). 7316–7316. 85 indexed citations

10.

Clark, David, Yuping Mei, Shisheng Sun, et al.. (2015). Glycoproteomic Approach Identifies KRAS as a Positive Regulator of CREG1 in Non-small Cell Lung Cancer Cells. Theranostics. 6(1). 65–77. 14 indexed citations

11.

Mei, Yuping, David Clark, & Mao Li. (2013). Novel dimensions of piRNAs in cancer. Cancer Letters. 336(1). 46–52. 99 indexed citations

12.

Younis, Rania H., Wei Cao, Ruxian Lin, et al.. (2012). CDC25AQ110del: A Novel Cell Division Cycle 25A Isoform Aberrantly Expressed in Non-Small Cell Lung Cancer. PLoS ONE. 7(10). e46464–e46464. 7 indexed citations

13.

Zhang, Jian, Yi Fu, Yuping Mei, Feng Jiang, & Joseph R. Lakowicz. (2010). Fluorescent Metal Nanoshell Probe to Detect Single miRNA in Lung Cancer Cell. Analytical Chemistry. 82(11). 4464–4471. 71 indexed citations

14.

Dou, Juan, Xiaofeng Li, Yun Cai, et al.. (2010). Human cytomegalovirus induces caspase-dependent apoptosis of megakaryocytic CHRF-288-11 cells by activating the JNK pathway. International Journal of Hematology. 91(4). 620–629. 7 indexed citations

15.

Liao, Jipei, Lei Yu, Yuping Mei, et al.. (2010). Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Molecular Cancer. 9(1). 198–198. 216 indexed citations

16.

Shen, Jun, Nevins W. Todd, Howard Zhang, et al.. (2010). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Laboratory Investigation. 91(4). 579–587. 318 indexed citations

17.

Li, Ting, Yun Su, Yuping Mei, et al.. (2009). ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Laboratory Investigation. 90(2). 234–244. 296 indexed citations

18.

Yuan, Zhongmin, Yuping Mei, Jing Zhou, et al.. (2007). E2F1 is not essential for apoptosis induced by potassium deprivation in cerebellar granule neurons. Neuroscience Letters. 424(3). 155–159. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact